Antonios Charokopos1, Matthew Griffin2, Veena S Rao2, Lesley Inker3, Krishna Sury4, Jennifer Asher5, Jeffrey Turner4, Devin Mahoney2, Zachary L Cox6, F Perry Wilson4, Jeffrey M Testani7. 1. Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. 2. Department of Internal Medicine, Section of Cardiovascular Medicine. 3. Department of Nephrology, Tufts Medical Center, Boston, Massachusetts; and. 4. Department of Internal Medicine, Section of Nephrology, and. 5. Department of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut. 6. Department of Pharmacy Practice, Lipscomb University College of Pharmacy, Nashville, Tennessee. 7. Department of Internal Medicine, Section of Cardiovascular Medicine, jeffrey.testani@yale.edu.
Abstract
BACKGROUND AND OBJECTIVES: Diuretic resistance can limit successful decongestion of patients with heart failure. Because loop diuretics tightly bind albumin, low serum albumin and high urine albumin can theoretically limit diuretic delivery to the site of action. However, it is unknown if this represents a clinically relevant mechanism of diuretic resistance in human heart failure. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 208 outpatients with heart failure at the Yale Transitional Care Center undergoing diuretic treatment were studied. Blood and urine chemistries were collected at baseline and 1.5 hours postdiuretic administration. Urine diuretic levels were normalized to urine creatinine and adjusted for diuretic dose administered, and diuretic efficiency was calculated as sodium output per doubling of the loop diuretic dose. Findings were validated in an inpatient heart failure cohort (n=60). RESULTS: Serum albumin levels in the outpatient cohort ranged from 2.4 to 4.9 g/dl, with a median of 3.7 g/dl (interquartile range, 3.5-4.1). Serum albumin had no association with urinary diuretic delivery (r=-0.05; P=0.52), but higher levels weakly correlated with better diuretic efficiency (r=0.17; P=0.02). However, serum albumin inversely correlated with systemic inflammation as assessed by plasma IL-6 (r=-0.35; P<0.001), and controlling for IL-6 eliminated the diuretic efficiency-serum albumin association (r=0.12; P=0.12). In the inpatient cohort, there was no association between serum albumin and urinary diuretic excretion (r=0.15; P=0.32) or diuretic efficiency (r=-0.16; P=0.25). In the outpatient cohort, 39% of patients had microalbuminuria, and 18% had macroalbuminuria. There was no correlation between albuminuria and diuretic efficiency after adjusting for kidney function (r=-0.02; P=0.89). Results were similar in the inpatient cohort. CONCLUSIONS: Serum albumin levels were not associated with urinary diuretic excretion, and urinary albumin levels were not associated with diuretic efficiency.
BACKGROUND AND OBJECTIVES: Diuretic resistance can limit successful decongestion of patients with heart failure. Because loop diuretics tightly bind albumin, low serum albumin and high urine albumin can theoretically limit diuretic delivery to the site of action. However, it is unknown if this represents a clinically relevant mechanism of diuretic resistance in humanheart failure. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 208 outpatients with heart failure at the Yale Transitional Care Center undergoing diuretic treatment were studied. Blood and urine chemistries were collected at baseline and 1.5 hours postdiuretic administration. Urine diuretic levels were normalized to urine creatinine and adjusted for diuretic dose administered, and diuretic efficiency was calculated as sodium output per doubling of the loop diuretic dose. Findings were validated in an inpatient heart failure cohort (n=60). RESULTS:Serum albumin levels in the outpatient cohort ranged from 2.4 to 4.9 g/dl, with a median of 3.7 g/dl (interquartile range, 3.5-4.1). Serum albumin had no association with urinary diuretic delivery (r=-0.05; P=0.52), but higher levels weakly correlated with better diuretic efficiency (r=0.17; P=0.02). However, serum albumin inversely correlated with systemic inflammation as assessed by plasma IL-6 (r=-0.35; P<0.001), and controlling for IL-6 eliminated the diuretic efficiency-serum albumin association (r=0.12; P=0.12). In the inpatient cohort, there was no association between serum albumin and urinary diuretic excretion (r=0.15; P=0.32) or diuretic efficiency (r=-0.16; P=0.25). In the outpatient cohort, 39% of patients had microalbuminuria, and 18% had macroalbuminuria. There was no correlation between albuminuria and diuretic efficiency after adjusting for kidney function (r=-0.02; P=0.89). Results were similar in the inpatient cohort. CONCLUSIONS:Serum albumin levels were not associated with urinary diuretic excretion, and urinary albumin levels were not associated with diuretic efficiency.
Authors: Jonathan G Amatruda; Rebecca Scherzer; Veena S Rao; Juan B Ivey-Miranda; Michael G Shlipak; Michelle M Estrella; Jeffrey M Testani Journal: Kidney Med Date: 2022-04-08
Authors: Tao Han Lee; George Kuo; Chih-Hsiang Chang; Yen Ta Huang; Chieh Li Yen; Cheng-Chia Lee; Pei Chun Fan; Jia-Jin Chen Journal: PLoS One Date: 2021-12-01 Impact factor: 3.240
Authors: Juan B Ivey-Miranda; Lesley A Inker; Matthew Griffin; Veena Rao; Christopher Maulion; Jeffrey M Turner; F Perry Wilson; W H Wilson Tang; Andrew S Levey; Jeffrey M Testani Journal: J Card Fail Date: 2020-08-01 Impact factor: 5.712
Authors: Zachary L Cox; James Fleming; Juan Ivey-Miranda; Matthew Griffin; Devin Mahoney; Keyanna Jackson; Daniel Z Hodson; Daniel Thomas; Nicole Gomez; Veena S Rao; Jeffrey M Testani Journal: ESC Heart Fail Date: 2020-09-06